These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 30368614

  • 1. Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort.
    Monet-Didailler C, Godron-Dubrasquet A, Madden I, Delmas Y, Llanas B, Harambat J.
    Pediatr Nephrol; 2019 Apr; 34(4):657-662. PubMed ID: 30368614
    [Abstract] [Full Text] [Related]

  • 2. Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome.
    Oakes RS, Kirkham JK, Nelson RD, Siegler RL.
    Pediatr Nephrol; 2008 Aug; 23(8):1303-8. PubMed ID: 18465151
    [Abstract] [Full Text] [Related]

  • 3. [Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].
    Bertholet-Thomas A, Ranchin B, King LA, Bacchetta J, Belot A, Gillet Y, Collardeau-Frachon S, Cochat P.
    Arch Pediatr; 2011 Jul; 18(7):823-30. PubMed ID: 21571510
    [Abstract] [Full Text] [Related]

  • 4. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
    Jenssen GR, Vold L, Hovland E, Bangstad HJ, Nygård K, Bjerre A.
    BMC Infect Dis; 2016 Jun 13; 16():285. PubMed ID: 27297224
    [Abstract] [Full Text] [Related]

  • 5. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL, Contrini MM, Glatstein E, Ayala SG, Santoro R, Ezcurra G, Teplitz E, Matsumoto Y, Sato H, Sakai K, Katsuura Y, Hoshide S, Morita T, Harning R, Brookman S.
    Pediatr Infect Dis J; 2012 Jan 13; 31(1):20-4. PubMed ID: 21829137
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Endothelial dysfunction during long-term follow-up in children with STEC hemolytic-uremic syndrome.
    Kreuzer M, Sollmann L, Ruben S, Leifheit-Nestler M, Fischer DC, Pape L, Haffner D.
    Pediatr Nephrol; 2017 Jun 13; 32(6):1005-1011. PubMed ID: 28180952
    [Abstract] [Full Text] [Related]

  • 8. [Hemolytic uremic syndrome caused by Shiga-toxin-producing Escherichia coli].
    Loirat C.
    Rev Prat; 2013 Jan 13; 63(1):11-6. PubMed ID: 23457821
    [Abstract] [Full Text] [Related]

  • 9. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.
    Ylinen E, Salmenlinna S, Halkilahti J, Jahnukainen T, Korhonen L, Virkkala T, Rimhanen-Finne R, Nuutinen M, Kataja J, Arikoski P, Linkosalo L, Bai X, Matussek A, Jalanko H, Saxén H.
    Pediatr Nephrol; 2020 Sep 13; 35(9):1749-1759. PubMed ID: 32323005
    [Abstract] [Full Text] [Related]

  • 10. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.
    Ardissino G, Vignati C, Masia C, Capone V, Colombo R, Tel F, Daprai L, Testa S, Dodaro A, Paglialonga F, Luini M, Brigotti M, Picicco D, Baldioli C, Pagani F, Ceruti R, Tommasi P, Possenti I, Cresseri D, Consonni D, Montini G, Arghittu M, ItalKid-HUS Network.
    J Pediatr; 2021 Oct 13; 237():34-40.e1. PubMed ID: 34197890
    [Abstract] [Full Text] [Related]

  • 11. Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumab.
    Ağbaş A, Göknar N, Akıncı N, Yıldırım ZY, Taşdemir M, Benzer M, Gökçe İ, Candan C, Küçük N, Uzuner S, Özçelik G, Demirkol D, Sever L, Çalışkan S.
    Pediatr Nephrol; 2018 Dec 13; 33(12):2371-2381. PubMed ID: 30159625
    [Abstract] [Full Text] [Related]

  • 12. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M, Mariani-Kurkdjian P, Gouali M, de Valk H, King LA, Le Hello S, Bonacorsi S, Loirat C.
    Med Mal Infect; 2018 May 13; 48(3):167-174. PubMed ID: 29054297
    [Abstract] [Full Text] [Related]

  • 13. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
    Mody RK, Luna-Gierke RE, Jones TF, Comstock N, Hurd S, Scheftel J, Lathrop S, Smith G, Palmer A, Strockbine N, Talkington D, Mahon BE, Hoekstra RM, Griffin PM.
    Arch Pediatr Adolesc Med; 2012 Oct 13; 166(10):902-9. PubMed ID: 22869280
    [Abstract] [Full Text] [Related]

  • 14. Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011.
    Werber D, King LA, Müller L, Follin P, Buchholz U, Bernard H, Rosner B, Ethelberg S, de Valk H, Höhle M.
    Am J Epidemiol; 2013 Sep 15; 178(6):984-92. PubMed ID: 23935124
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term outcomes of Shiga toxin hemolytic uremic syndrome.
    Spinale JM, Ruebner RL, Copelovitch L, Kaplan BS.
    Pediatr Nephrol; 2013 Nov 15; 28(11):2097-105. PubMed ID: 23288350
    [Abstract] [Full Text] [Related]

  • 17. CHARACTERISTICS OF DIARRHEAL DISEASE COMPLICATED WITH HEMOLYTIC UREMIC SYNDROME AMONG CHILDREN IN GEORGIA, 2009-2016.
    Chokoshvili O, Vepkhvadze N, Davitaia T, Tevzadze L, Tsertsvadze T.
    Georgian Med News; 2018 Oct 15; (283):123-129. PubMed ID: 30516507
    [Abstract] [Full Text] [Related]

  • 18. Outbreak of hemolytic uremic syndrome with unusually severe clinical presentation caused by Shiga toxin-producing Escherichia coli O26:H11 in France.
    Minary K, Tanne C, Kwon T, Faudeux C, Clave S, Langevin L, Pietrement C, Enoch C, Parmentier C, Mariani-Kurkdjian P, Weill FX, Jones G, Djouadi N, Morin D, Fila M.
    Arch Pediatr; 2022 Aug 15; 29(6):448-452. PubMed ID: 35662540
    [Abstract] [Full Text] [Related]

  • 19. Outcome of children with Shiga toxin-associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study.
    Monet-Didailler C, Chevallier A, Godron-Dubrasquet A, Allard L, Delmas Y, Contin-Bordes C, Brissaud O, Llanas B, Harambat J.
    Nephrol Dial Transplant; 2020 Dec 04; 35(12):2147-2153. PubMed ID: 31411695
    [Abstract] [Full Text] [Related]

  • 20. Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Société de Néphrologie Pédiatrique.
    Decludt B, Bouvet P, Mariani-Kurkdjian P, Grimont F, Grimont PA, Hubert B, Loirat C.
    Epidemiol Infect; 2000 Apr 04; 124(2):215-20. PubMed ID: 10813145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.